Close Menu
    Trending
    • 2026 Canton Fair Design Award Winners Showcase China’s Innovation Strength
    • NTL HEALTHCARE Wraps Up WHX Johannesburg 2026, Accelerating African Market Expansion
    • stc group unveils its vision for AI-native networks at Network X 2026
    • Guterres warns a million species at risk ahead of COP17
    • Brent oil touches $110 for first time since May
    • EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
    • Egyptian expat remittances surge 27.2% to $33.9 billion
    • Samsung charts next-generation memory path for AI systems
    • Home
    • Contact Us
    Irani TimesIrani Times
    Monday, October 19
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Irani TimesIrani Times
    Home » MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market
    PR Newswire

    MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

    September 26, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea, Sept. 26, 2026 /PRNewswire/ — MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market.

    Rather than relying on a single trending ingredient, HYALMASS AQUATOX brings together five high-interest active ingredients — PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid — in one advanced aesthetic formulation.

    Five Powerful Actives. One Advanced Formula.

    Botulinum Peptide — designed to support a smoother, more refined skin appearance
    GHK-Cu — a copper peptide widely studied for skin conditioning and regeneration-related applications
    Succinic Acid — recognized for its role in skin revitalization and antioxidant-related activity
    PDRN — associated with skin regeneration and recovery
    Exosomes — increasingly recognized for their role in advanced skin rejuvenation approaches

    By combining these highly sought-after ingredients, HYALMASS AQUATOX aims to address the growing global demand for multifunctional, ingredient-driven aesthetic solutions.

    A New Chapter for the HYALMASS Portfolio

    The launch follows the growing international interest in HYALMASS AQUA EXOSOME, strengthening MAYPHARM’s expanding presence in the global aesthetic market.

    As demand for advanced skin rejuvenation products continues to develop, the market has also seen an increasing number of products adopting similar ingredient concepts, visual identities, and positioning. MAYPHARM therefore emphasizes the importance of product authenticity and authorized distribution when purchasing HYALMASS products.

    Distributors, aesthetic professionals, and customers are encouraged to verify the original manufacturer, authorized supply channel, packaging, and official product information before purchasing or using HYALMASS products.

    Innovation That Moves With the Market

    With HYALMASS AQUATOX, MAYPHARM continues to expand its portfolio around emerging aesthetic trends while combining multiple high-interest actives into a single product concept.

    Five actives. One formula. A new direction for advanced skin care.

    HYALMASS AQUATOX — Coming Soon.

    Choose the Original. Choose MAYPHARM.

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/maypharm-unveils-hyalmass-aquatox-a-next-generation-multi-active-skin-solution-for-the-global-aesthetic-market-302890709.html

    Related Posts

    2026 Canton Fair Design Award Winners Showcase China’s Innovation Strength

    October 19, 2026

    NTL HEALTHCARE Wraps Up WHX Johannesburg 2026, Accelerating African Market Expansion

    October 19, 2026

    stc group unveils its vision for AI-native networks at Network X 2026

    October 19, 2026

    EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs

    October 17, 2026

    Huawei and State Information Center Release AI CITY Development Research Report and Launch Global AI CITY Innovation & Development Ecosystem Alliance

    October 16, 2026

    HiTHIUM Surpasses 200GWh in Shipments, Advancing Global Long-Duration Energy Storage with Full-Chain Integration

    October 16, 2026
    Latest News

    Guterres warns a million species at risk ahead of COP17

    October 17, 2026

    Brent oil touches $110 for first time since May

    October 17, 2026

    Egyptian expat remittances surge 27.2% to $33.9 billion

    October 16, 2026

    Samsung charts next-generation memory path for AI systems

    October 16, 2026
    © 2026 Irani Times | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.